Literature DB >> 16670319

Defective adhesion in tumor infiltrating CD8+ T cells.

Mythili Koneru1, Ngozi Monu, David Schaer, Justine Barletta, Alan B Frey.   

Abstract

CD8(+) tumor-infiltrating lymphocytes (TIL) are defective in cytolysis due to tumor-induced inhibition of proximal TCR-mediated signaling, a defect that is relieved upon purification and brief culture. We show in this study that frequency of conjugation in vitro of nonlytic TIL with tumor cells is low in comparison with their lytic counterparts, and the strength of interaction and duration of conjugation are also reduced. Previous reports show that p56(lck) activation is required for TCR-initiated LFA-1 avidity up-regulation, raising the question: is low LFA-1 avidity the basis of reduced TIL conjugation frequency? When stimulated with phorbol ester, nonlytic TIL bind purified ICAM-1 equivalently as lytic TIL, suggesting that LFA-1 can be activated if proximal TCR signaling is bypassed. However, when treated with phorbol ester, the conjugation frequency of nonlytic TIL does not increase. CD2 and CD8 also mediate T cell adhesion to cognate target cells and are both expressed at lower levels in nonlytic TIL in addition to being excluded from the immune synapse formed upon conjugation. Collectively, these results imply that adhesion defects in nonlytic TIL result from a combination of decreased cell surface levels of adhesion molecules, deficient LFA-1 activation, and the failure to recruit essential adhesion receptors to the membrane contact site formed with cognate target cells.

Entities:  

Mesh:

Year:  2006        PMID: 16670319     DOI: 10.4049/jimmunol.176.10.6103

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.

Authors:  Ngozi Monu; Alan B Frey
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

Review 2.  Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phase.

Authors:  Edwin J Vazquez-Cintron; Ngozi R Monu; Alan B Frey
Journal:  J Immunol       Date:  2010-12-15       Impact factor: 5.422

3.  Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer.

Authors:  Lina Liu; Yuhua Wang; Lei Miao; Qi Liu; Sara Musetti; Jun Li; Leaf Huang
Journal:  Mol Ther       Date:  2017-12-05       Impact factor: 11.454

4.  Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells.

Authors:  Candace M Cham; Gregory Driessens; James P O'Keefe; Thomas F Gajewski
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

Review 5.  Signaling defects in anti-tumor T cells.

Authors:  Alan B Frey; Ngozi Monu
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

6.  Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma.

Authors:  Hans-Udo Kasper; Uta Drebber; Dirk-Ludger Stippel; Hans-Peter Dienes; Anton Gillessen
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

Review 7.  Mobilizing the low-avidity T cell repertoire to kill tumors.

Authors:  Rachel H McMahan; Jill E Slansky
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

Review 8.  Promises and challenges of adoptive T-cell therapies for solid tumours.

Authors:  Matteo Morotti; Ashwag Albukhari; Abdulkhaliq Alsaadi; Mara Artibani; James D Brenton; Stuart M Curbishley; Tao Dong; Michael L Dustin; Zhiyuan Hu; Nicholas McGranahan; Martin L Miller; Laura Santana-Gonzalez; Leonard W Seymour; Tingyan Shi; Peter Van Loo; Christopher Yau; Helen White; Nina Wietek; David N Church; David C Wedge; Ahmed A Ahmed
Journal:  Br J Cancer       Date:  2021-03-29       Impact factor: 7.640

9.  Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscope.

Authors:  David A Schaer; Yongbiao Li; Taha Merghoub; Gabrielle A Rizzuto; Amos Shemesh; Adam D Cohen; Yanyun Li; Francesca Avogadri; Ricardo Toledo-Crow; Alan N Houghton; Jedd D Wolchok
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

10.  Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells.

Authors:  Edwin J Vazquez-Cintron; Ngozi R Monu; Jeremy C Burns; Roy Blum; Gregory Chen; Peter Lopez; Jennifer Ma; Sasa Radoja; Alan B Frey
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.